Dunn RJ
The Adrenal insufficiency page has been updated, including changes to reflect that Addison’s disease can refer to all forms of primary adrenal insufficiency, not just auto-immune mediated disease. Thanks to Michael for picking this up.
The Hyperkalaemia page has had an update, including the most common contributors in ED patients.
The Anti-psychotic agents page has been updated, including significant revision of the segment on quetiapine.
The Other movement disorders page has been updated, including revision of the segment on Hemiballismus.
The Post partum haemorrhage page has been significantly revised and updated.
The Abnormal presentations page has been updated with a significant revision of the segment on Shoulder dystocia.
The Normal labour and delivery page has been revised and updated in multiple ways.
The Clotting factor replacement page has had a number of small changes to improve clarity.
The Reversal of anti-coagulation page has been revised, updated and made more concise.
The Other anticoagulants page has been updated with information about expected therapeutic rivaroxaban levels.
The Stroke management page has been updated to include recommended agents to control BP in stroke.
The Stroke page has been updated with a short segment on missed stroke.
A new page called Evidence for thrombolytic therapy in stroke has been created from the content previously on the Thrombolytic therapy in stroke page.
The Investigation of stroke and Stroke management pages have been revised.
The Thrombolystic therapy in stroke page has had a major revision to improve clarity and conciseness. Sections addressing time based and perfusion based strategies have been added.
The Oxygen therapy page has been updated, including a clearer indication that target SpO2 in hospitalised patients should rarely be > 95%.
The Mechanical cardiovascular support page has been updated to downplay the usefulness of IABP in cardiogenic shock.
The Assessment of atrial fibrillation or flutter page has been updated with the addition of genetic factors and channelopathies as causes for AF.
The Stroke prevention in atrial fibrillation page has been significantly revised, simplified and updated, reflecting the improved understanding we have of DOACs and anti-platelet agents.
The Assessment of atrial fibrillation or flutter page has been updated with the removal of the CHADS2 score and replacement of the CHA2DS2VASc score with the CHA2DSVA score.